Global Bacillary Dysentery Drug Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3200/- USD | Published Date: April 7, 2021 |

The global bacillary dysentery drugs market size is accounted to register a significant CAGR of 3.6% over the forecast period and expected to reach USD 1,712 million by 2027. Rising prevalence of bacillary dysentery infections in the developing regions of the world primarily drives the market growth. Furthermore looming threat of microbial resistance and effective implementation of treatment regimen will further bolster the bacillary dysentery drugs market growth.

Bacillary dysentery is also popularly called as shigellosis, it still remains the cause of high mortality rate in the pediatric patients worldwide. It is basically a gram negative non-motile bacillus microorganism belonging to the family enterobacteriacae present in 4 strains such as S. flexneri, S. dysenteriae, S. sonnei, S. dysenteriae etc.

Market Segment Insights:

Beta lactams are representing the largest market share in the drug class segment for bacillary dysentery drugs market. It is always prescribed in combination with either penicillin or cephalosporin to increase its bactericidal spectrum of activity against microorganism responsible for the occurrence of bacillary dysentery. It is the first line therapy drug and is prescribed for 5 days to decrease the concentration of Shiga toxin (Stx) concentrations in the stool and thereby accelerates the elimination of Shigella and the subsequent spread of infection. Quinolones are ready to showcase exemplary market growth performance during the forecast period on account of low microbial resistance observed against ciprofloxacin and clinical studies have confirmed its broad spectrum activity against all the strains of Shigella strains.

Global Bacillary Dysentery Drugs Market

To know more about the study, request a report sample

Hospital pharmacy is currently dominating the distribution channel segment for bacillary dysentery drugs market. Dispensing of antibiotics varies as per the treatment regimen adopted by physicians in different parts of the globe hence precise compounding by hospital pharmacist is inevitable to negate the occurrence of drug related adverse events. Retail pharmacy is expected to register comfortable market growth in the near future on account of the availability of cheap medicines due to government subsidy awarded for essential medicines and capacity to serve the medicinal requirements of patients residing in the remote locations.

The bacillary dysentery drugs comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2020 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The bacillary dysentery drugs market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2018-19 – Historical Year
  • 2020 – Base Year
  • 2021-2027 – Forecast Period

Global Bacillary Dysentery Drugs Market Segmentation:

By Drug Class:

  • Beta Lactams
  • Quinolones
  • Macrolides
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

Asia Pacific is presently leading the geography segment for bacillary dysentery drugs market. Rising prevalence of bacillary dysentery infection primarily drives the market growth in the region. As per the recent information provided by the National Institute of Health the annual incidence rate of bacillary dysentery in the South Asian countries is 13.2 per 1,000 individuals. Increasing urbanization, rising water and soil pollution, lack of civic amenities in the slum dwelling together accentuate the market growth in the region. Europe is the second largest regional segment on account of the effective implementation of treatment guidelines pertaining to bacillary dysentery treatment as sanctioned by the European Medical Agency (EMA) for the region. North America is anticipated to be the fastest growing regional segment for bacillary dysentery drugs market. Affordable reimbursement scenario and developed healthcare infrastructure together accentuate the market growth in the region.

Market Competition Assessment:

Key players operating in the global bacillary dysentery drugs market are Aurobindo Pharma, Sun Pharmaceutical Limited, Cipla Limited, GlaxoSmithKline, Plc., and Mylan Pharmaceutical Industries Ltd. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Apotex Corporation
  • Aurobindo Pharma
  • Cipla Limited
  • GlaxoSmithKline, Plc.
  • Sun Pharmaceutical Limited
  • Reddys Laboratories Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Sanofi Aventis
  • Mylan Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Key Questions Answered by Bacillary Dysentery Drugs Market Report:

  • Global bacillary dysentery drugs market forecasts from 2021-2027
  • Regional bacillary dysentery drugs market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
  • Bacillary dysentery drugs submarket forecasts from 2021-2027 covering the market by drug class, by distribution channel, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis pertaining to bacillary dysentery drugs market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country-level bacillary dysentery drugs markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the bacillary dysentery drugs market
Table of Content:

Chapter 1. Introduction

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Scope
1.3.1. Market Segmentation
1.3.2. Years Considered for the Study
1.4. Currency
1.5. Limitation
1.6. Market Stakeholders

 

Chapter 2. Research Methodology


2.1. Market Size Estimation
2.2. Market Breakdown and Data Triangulation
2.3. Market Share Estimation
2.4. Key Data From Secondary Sources
2.5. Key Data From Primary Sources
2.6. Key Industry Insights
2.7. Assumptions for the Study

 

Chapter 3. Executive Summary


3.1. Global Bacillary Dysentery Drugs Market Snapshot
3.2. Global Bacillary Dysentery Drugs Market, by Drug Class, 2019 (US$ Mn)
3.3. Global Bacillary Dysentery Drugs Market, By Distribution Channel, 2019 (US$ Mn)
3.4. Global Bacillary Dysentery Drugs Market, by Geography, 2019 (US$ Mn)

 

Chapter 4. Bacillary Dysentery Drugs Market: Dynamics and Future Outlook


4.1. Market Overview
4.2. Drivers
4.3. Challenges
4.4. Opportunities
4.5. Attractive Investment Proposition, by Geography, 2019
4.6. Pipeline Analysis

 

Chapter 5. Global Bacillary Dysentery Drugs Market, by Drug Class


5.1. Introduction
5.2. Beta Lactams
5.3. Quinolones
5.4. Macrolides
5.5. Others

 

Chapter 6. Global Bacillary Dysentery Drugs Market, By Distribution Channel


6.1. Introduction
6.2. Hospital Pharmacy
6.3. Retail Pharmacy
6.4. Others

 

Chapter 7. Global Bacillary Dysentery Drugs Market, by Geography


7.1. Introduction
7.1. North America Bacillary Dysentery Drugs Market Analysis, 2017 – 2027
7.1.1. North America Bacillary Dysentery Drugs Market, by Drug Class, 2017 – 2027 (US$ Mn)
7.1.2. North America Bacillary Dysentery Drugs Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.1.3. North America Bacillary Dysentery Drugs Market, by Country, 2017 – 2027 (US$ Mn)
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe Bacillary Dysentery Drugs Market Analysis, 2017 – 2027
7.2.1. Europe Bacillary Dysentery Drugs Market, by Drug Class, 2017 – 2027 (US$ Mn)
7.2.2. Europe Bacillary Dysentery Drugs Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.2.3. Europe Bacillary Dysentery Drugs Market, by Country, 2017 – 2027 (US$ Mn)
7.2.3.1. U.K.
7.2.3.2. Germany
7.2.3.3. Russia
7.2.3.4. France
7.2.3.5. Italy
7.2.3.6. Spain
7.2.3.7. Ukraine
7.2.3.8. Rest of Europe
7.3. Asia Pacific Bacillary Dysentery Drugs Market Analysis, 2017 – 2027
7.3.1. Asia Pacific Bacillary Dysentery Drugs Market, by Drug Class, 2017 – 2027 (US$ Mn)
7.3.2. Asia Pacific Bacillary Dysentery Drugs Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.3.3. Asia Pacific Bacillary Dysentery Drugs Market, by Country, 2017 – 2027 (US$ Mn)
7.3.3.1. China
7.3.3.2. Japan
7.3.3.3. Rest of Asia Pacific
7.4. Latin America Bacillary Dysentery Drugs Market Analysis, 2017 – 2027
7.4.1. Latin America Bacillary Dysentery Drugs Market, by Drug Class, 2017 – 2027 (US$ Mn)
7.4.2. Latin America Bacillary Dysentery Drugs Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.4.3. Latin America Bacillary Dysentery Drugs Market, by Country, 2017 – 2027 (US$ Mn)
7.4.3.1. Brazil
7.4.3.2. Mexico
7.4.3.3. Rest of Latin America
7.5. Middle East and Africa Bacillary Dysentery Drugs Market Analysis, 2017 – 2027
7.5.1. MEA Bacillary Dysentery Drugs Market, by Drug Class, 2017 – 2027 (US$ Mn)
7.5.2. MEA Bacillary Dysentery Drugs Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.5.3. MEA Bacillary Dysentery Drugs Market, by Country/Region, 2017 – 2027 (US$ Mn)
7.5.3.1. GCC
7.5.3.2. Rest of MEA

 

Chapter 8. Company Profiles


8.1. Apotex Corporation
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Recent Developments
8.1.5. SWOT Analysis
8.2. Aurobindo Pharma
8.3. Cipla Limited
8.4. GlaxoSmithKline, Plc.
8.5. Sun Pharmaceutical Limited
8.6. Dr. Reddys Laboratories Ltd.
8.7. Lupin Pharmaceuticals, Inc.
8.8. Sanofi Aventis
8.9. Mylan Pharmaceutical Industries Ltd.
8.10. Teva Pharmaceutical Industries Ltd.

To know more about the study, request a report sample

List of Figures:

FIG. 1 Bacillary Dysentery Drugs: Market Segmentation
FIG. 2 Global Bacillary Dysentery Drugs Market, by Drug Class, 2019 (US$ Mn)
FIG. 3 Global Bacillary Dysentery Drugs Market, By Distribution Channel, 2019 (US$ Mn)
FIG. 4 Global Bacillary Dysentery Drugs Market, by Geography, 2019 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2019
FIG. 6 Global Beta Lactams Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 7 Global Quinolones Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 8 Global Macrolides Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 9 Global Other Drug Class Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 10 Global Hospital Pharmacy Market for Bacillary Dysentery Drugs, 2017 – 2027 (US$ Mn)
FIG. 11 Global Retail Pharmacy Market for Bacillary Dysentery Drugs, 2017 – 2027 (US$ Mn)
FIG. 12 Global Other Distribution Channel Market for Bacillary Dysentery Drugs, 2017 – 2027 (US$ Mn)
FIG. 13 U.S. Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 14 Canada Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 15 U.K. Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 16 Germany Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 17 Russia Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 18 France Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 19 Italy Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 20 Spain Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 21 Ukraine Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 22 Rest of Europe Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 23 China Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 24 Japan Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 25 Rest of Asia Pacific Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 26 Brazil Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 27 Mexico Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 28 Rest of Latin America Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 29 GCC Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 30 Rest of MEA Bacillary Dysentery Drugs Market, 2017 – 2027 (US$ Mn)
FIG. 31 Bacillary Dysentery Drugs Market: Research Methodology

To know more about the study, request a report sample

List of Tables:

TABLE 1 Global Bacillary Dysentery Drugs Market Snapshot
TABLE 2 Global Bacillary Dysentery Drugs Market, by Drug Class, 2017 – 2027 (US$ Mn)
TABLE 3 Global Bacillary Dysentery Drugs Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 4 Global Bacillary Dysentery Drugs Market, by Geography, 2017 – 2027 (US$ Mn)
TABLE 5 North America Bacillary Dysentery Drugs Market, by Drug Class, 2017 – 2027 (US$ Mn)
TABLE 6 North America Bacillary Dysentery Drugs Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 7 North America Bacillary Dysentery Drugs Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 8 Europe Bacillary Dysentery Drugs Market, by Drug Class, 2017 – 2027 (US$ Mn)
TABLE 9 Europe Bacillary Dysentery Drugs Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 10 Europe Bacillary Dysentery Drugs Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 11 Asia Pacific Bacillary Dysentery Drugs Market, by Drug Class, 2017 – 2027 (US$ Mn)
TABLE 12 Asia Pacific Bacillary Dysentery Drugs Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 13 Asia Pacific Bacillary Dysentery Drugs Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 14 Latin America Bacillary Dysentery Drugs Market, by Drug Class, 2017 – 2027 (US$ Mn)
TABLE 15 Latin America Bacillary Dysentery Drugs Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 16 Latin America Bacillary Dysentery Drugs Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 17 Middle East and Africa Bacillary Dysentery Drugs Market, by Drug Class, 2017 – 2027 (US$ Mn)
TABLE 18 Middle East and Africa Bacillary Dysentery Drugs Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 19 Middle East and Africa Bacillary Dysentery Drugs Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 20 Apotex Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 21 Aurobindo Pharma: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 22 Cipla Limited.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 23 GlaxoSmithKline, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 24 Sun Pharmaceutical Limited: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 25 Dr. Reddys Laboratories Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 26 Lupin Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 27 Sanofi Aventis: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 28 Mylan Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
TABLE 29 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
Fill the given form to inquiry before buying for Bacillary Dysentery Drug Market Report

Your Designtaion (required):


(Additional country analysis and conmapny analysis will be added according to request, please read our FAQs below:)(Reports covers the COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying



Frequently Asked Questions (FAQs):
A. Yes, we provide customization with every report to fulfill your market research requirement.
A. No, generally we don’t charge for report customization.
A. Yes, we will add the more coutries analysis in the report, please mention the countries you are looking.
A. Yes, we provide research support for all our clients to resolve their issue regarding the report.
A. Yes, you can purchase only a regional or a country market report with our best price which is less than the global report.
A. Yes, we provide a better discount for startups and individuals.
A. Our database consists of over 70,000 market research reports; if still not available on the website, feel free to write us. Our team will be happy to assist you in the same. Let us know if you are looking for the dataset.
(For more information, feel free to write us at sales@researchcorridor.com)
Select License Type
$3600/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client are returning clients
  • 100,000+ data points in our comprehensive database
  • 24x5 availability - we are always there when you need us
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report

Impacts of COVID-19
COVID-19 Impact on the Bacillary Dysentery Drug Market

For Any Assitance

Call Us: +1 520-686-7060
Email: sales@researchcorridor.com

Our Clients